<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Novavax Inc (NASDAQ: NVAX) said its two-dose COVID-19 vaccine effectively generates an immune response against the Omicron variant, according to early data. Though the company said neutralization against the Omicron variant was “4-fold lower” than it was against the original strain of the virus, suggesting that a booster shot or a new Omicron-specific vaccine would be beneficial.
...read full article on Benzinga
